PL2014771T3 - Ciągły proces hydrolizy enzymatycznej - Google Patents

Ciągły proces hydrolizy enzymatycznej

Info

Publication number
PL2014771T3
PL2014771T3 PL07110957T PL07110957T PL2014771T3 PL 2014771 T3 PL2014771 T3 PL 2014771T3 PL 07110957 T PL07110957 T PL 07110957T PL 07110957 T PL07110957 T PL 07110957T PL 2014771 T3 PL2014771 T3 PL 2014771T3
Authority
PL
Poland
Prior art keywords
enzymatic hydrolysis
hydrolysis process
continuous enzymatic
continuous
hydrolysis
Prior art date
Application number
PL07110957T
Other languages
English (en)
Inventor
Fabrice Gallou
Pascal Beney
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of PL2014771T3 publication Critical patent/PL2014771T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL07110957T 2007-06-25 2007-06-25 Ciągły proces hydrolizy enzymatycznej PL2014771T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07110957.3A EP2014771B1 (en) 2007-06-25 2007-06-25 Continuous enzymatic hydrolysis process

Publications (1)

Publication Number Publication Date
PL2014771T3 true PL2014771T3 (pl) 2015-05-29

Family

ID=39111421

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07110957T PL2014771T3 (pl) 2007-06-25 2007-06-25 Ciągły proces hydrolizy enzymatycznej

Country Status (13)

Country Link
US (2) US20110091943A1 (pl)
EP (1) EP2014771B1 (pl)
JP (1) JP5559046B2 (pl)
CN (1) CN101720333B (pl)
AU (1) AU2008268384B2 (pl)
CA (1) CA2692437C (pl)
DK (1) DK2014771T3 (pl)
ES (1) ES2530763T3 (pl)
MX (1) MX2009014280A (pl)
PL (1) PL2014771T3 (pl)
SI (1) SI2014771T1 (pl)
TW (1) TWI438280B (pl)
WO (1) WO2009003042A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
SG11201407336PA (en) 2012-05-25 2015-03-30 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
GEP201706757B (en) 2012-12-21 2017-10-25 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
EP3055319A4 (en) 2013-10-11 2018-01-10 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CA3182565A1 (en) 2015-03-06 2016-09-15 Atea Pharmaceuticals, Inc. .beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
DK3512863T3 (da) 2016-09-07 2022-03-07 Atea Pharmaceuticals Inc 2¿-substituerede-N6-substituerede purinnukleotider til behandling af RNA-virus
CN115477679A (zh) 2017-02-01 2022-12-16 阿堤亚制药公司 用于治疗丙型肝炎病毒的核苷酸半硫酸盐
EP3773753A4 (en) 2018-04-10 2021-12-22 ATEA Pharmaceuticals, Inc. TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
KR20240022574A (ko) 2021-06-17 2024-02-20 아테아 파마슈티컬즈, 인크. 유리한 항-hcv 조합 요법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836432A (en) * 1969-09-25 1974-09-17 Hokkaido Sugar Co Continuous process for the hydrolysis of raffinose
FR2648147B1 (fr) * 1989-06-13 1991-08-16 Gattefosse Ets Sa Procede pour la preparation de beta-monoglycerides et produits obtenus
US5538891A (en) * 1991-09-02 1996-07-23 Boehringer Mannheim Gmbh Process for enzymatic production of isomerically pure isosorbide-2 and 5-monoesters and their conversion to isosorbide-2 and -5 nitrate
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
US6833471B2 (en) * 2002-09-09 2004-12-21 Biocatalytics, Inc. Methods for producing hydroxy amino acids and derivatives thereof
US20080070852A1 (en) * 2004-06-07 2008-03-20 Averett Devron R 3-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses Thereof
DE102005002700A1 (de) * 2005-01-19 2006-07-27 Cognis Deutschland Gmbh & Co. Kg Zusammensetzungen verwendbar als Biotreibstoff

Also Published As

Publication number Publication date
CA2692437A1 (en) 2008-12-31
AU2008268384A1 (en) 2008-12-31
MX2009014280A (es) 2010-06-23
US20130137143A1 (en) 2013-05-30
CN101720333B (zh) 2012-08-29
JP2011500001A (ja) 2011-01-06
EP2014771B1 (en) 2014-12-03
CN101720333A (zh) 2010-06-02
ES2530763T3 (es) 2015-03-05
EP2014771A1 (en) 2009-01-14
TW200911997A (en) 2009-03-16
WO2009003042A1 (en) 2008-12-31
AU2008268384B2 (en) 2013-09-26
TWI438280B (zh) 2014-05-21
HK1126820A1 (en) 2009-09-11
CA2692437C (en) 2016-04-19
JP5559046B2 (ja) 2014-07-23
US20110091943A1 (en) 2011-04-21
DK2014771T3 (en) 2015-03-09
SI2014771T1 (sl) 2015-04-30

Similar Documents

Publication Publication Date Title
SI2014771T1 (sl) Kontinuiran postopek encimske hidrolize
SG10201506935QA (en) Enzymatic process
GB0711624D0 (en) Process
GB0706978D0 (en) Process
PL2772543T3 (pl) Enzymatyczny proces wytwarzania beta-santalenu i odpowiadającego mu enzymu
GB0716126D0 (en) Process
GB0714602D0 (en) Process
GB0711680D0 (en) Process
EP2229583A4 (en) Monitoring enzymatic process
IL190914A0 (en) Production of dolasetron
GB0700074D0 (en) process
GB0714390D0 (en) Process
PL2173197T3 (pl) Sposób
GB0804721D0 (en) Enzyme
GB0700878D0 (en) Process
GB0818328D0 (en) Novel enzyme
GB0724716D0 (en) Process
GB0709689D0 (en) Process
GB0804722D0 (en) Enzyme
GB0800831D0 (en) Enzymes 1
GB0701966D0 (en) Process
HU0700089D0 (en) Hydrolysis
AU2008903814A0 (en) Enzyme hydrolysis method
GB0903266D0 (en) Enzymatic process
GB0910808D0 (en) Enzymatic process